At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 33 enrolled
Drug / intervention
BPX-01, 1% Topical Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes
In Brief
A Phase 2 clinical trial evaluating BPX-01, 1% Topical Gel and BPX-01 Vehicle Gel for Acne Vulgaris. Completed, enrolled 33 participants across 1 site.
Detailed Summary
This is a Phase 2a study which is being conducted in healthy volunteers in order to evaluate the comparative reduction of Propionibacterium acnes in-vivo following once daily topical administration of BPX-01 Minocycline 1% Topical Gel (BPX-01) or BPX-01 Vehicle control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 2016
Enrollment StartApr 2016
Primary CompletionJun 2016
TodayJul 2026
First PostedMar 15, 2016
Enrollment StartApr 1, 2016
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.3 years ago
Interventions
BPX-01, 1% Topical Geldrug
topical gel, applied to the forehead, cheeks, nose and chin
BPX-01 Vehicle Geldrug
topical gel, applied to the forehead, cheeks, nose and chin